Past EventApril 24, 2014 – Investments in Precision Medicine
Kristin Ciriello Pothier of Ernst & Young will be our presenter.
Kristin is a Partner in Transaction Advisory Services at EY. She has over 18 years of experience in management consulting and genomics research in the life sciences industry. Her primary areas of focus are company and investor commercial strategy and M&A support for diagnostics, life science research, and pharmaceutical companies focused on targeted therapeutics and personalized medicine. She is a noted speaker, workshop leader, and writer in the life sciences space. She is also a founder of DxInsights, a non-profit organization designed to educate on the impact of diagnostics in improving health care outcomes to the nation’s healthcare communities. Earlier in her career, Kristin was a partner and owner of Health Advances, a boutique healthcare consulting firm and a research scientist at Genome Therapeutics and at Genzyme. She earned an undergraduate degree in Biochemistry from Smith College and a graduate degree in Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health.